99mTc-labeled σ-receptor-binding complex: Synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells

Bioconjugate Chemistry

Volumn 8, Issue 3, 1997, Pages 304-309

  John, Christy S ^a   Lim, Benjamin B ^a   Geyer, Brian C ^a   Vilner, Bertold J ^b   Bowen, Wayne D ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; BIOACTIVITY; CELLS; CYTOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGANDS; PHARMACODYNAMICS; TUMORS;

BINDING COMPLEXES; BREAST CARCINOMAS; HIGHER YIELD; HUMAN BREAST; HUMAN TUMOR CELLS; LABELINGS; PHARMACOPHORES; RECEPTOR BINDING; SPECIFIC BINDING; SYNTHESISED;

CHELATION;

CAVIA PORCELLUS; SUS SCROFA;

DIAGNOSTIC AGENT; LIGAND; SIGMA OPIATE RECEPTOR; TECHNETIUM;

ANIMAL; ARTICLE; BINDING COMPETITION; BREAST TUMOR; CELL CULTURE; FEMALE; GUINEA PIG; HUMAN; METABOLISM; PAGET NIPPLE DISEASE; RAT; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; BINDING, COMPETITIVE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GUINEA PIGS; HUMANS; LIGANDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0030609924     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9700087     Document Type: Article

References (27)

1. (a) Hellewell, S. B., and Bowen, W. D. (1990) A σ-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different σ-receptor form from that in guinea pig brain. Brain Res. 527, 244-253.
2. (b) Quirion, R., Bowen, W. D., Itzhak, Y., Junien, J. L., Musacchio, J. M., Rothman, R. B., Su, T. P., Tam, S. W., and Taylor, D. P. (1992) A proposal for the classification of a binding sites. Trends Pharmacol. Sci. 13, 85-86.
3. 3H](+)-Pentazocine: A potent and highly selective benzomorphan-based probe for σ-1 receptors. Mol. Neuropharmacol. 3, 117-126.
4. 3H](+)-pentazocine, a highly potent and selective radioligand for σ receptors. FEBS Lett. 251, 53-58.
5. 3H]tolyl)guanidine: a selective ligand that labels σ type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 83, 8784-8788.
6. Vilner, B. J., John, C. S., and Bowen, W. D. (1995) σ-1 and σ-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55, 408-413.
7. (a) Thomas, G. E., Szucs, M., Mamone, J. Y., Bem, W. T., Rush, M. D., Johnson, F. E., and Coscia, C. J. (1990) σ and opioid receptors in human brain tumors. Life Sci. 46, 1279-1286.
8. (b) Bem, W. T., Thomas, G. E., Mamome, J. Y., Homan, S. M., Levy, B. K., Johnson, F. E., and Coscia, C. J. (1991) Overexpression of σ-receptors in nonneural human tumors. Cancer Res. 51, 6558-6562.
9. (c) John, C. S., Vilner, B. J., Schwartz, A. M., and Bowen, W. D. (1996) Characterization of σ-receptor binding sites in human biopsied solid breast tumors. J. Nucl. Med. 37, 267P (abstract).
10. John, C. S., Bowen, W. D., Saga, T., Kinuya, S., Vilner, B. J., Baumgold, J., Paik, C. H., Reba R. C., Neumann, R. D., Varma, V. M., and McAfee, J. G. (1993) A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinyl-aminoethyl)-4-iodobenzamide. J. Nucl. Med. 34, 2169-2175.
11. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide, a new σ-receptor radiopharmaceutical: high affinity binding to MCF-7 breast tumor cells. J. Med. Chem. 37, 1737-1739.
12. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity σ-receptor ligand for potential imaging of breast cancer. Cancer Res. 55, 3022-3027.
13. John, C. S., Bowen, W. D., Varma, V. M., McAfee, J. G., and Moody, T. W. (1995) σ-Receptors are expressed in human non-small cell lung carcinoma. Life Sci. 56, 2385-2392.
14. (a) John, C. S., Venugopal, R., Li, J., Bowen, W. D., Varma, V. M., and Thakur, M. L. (1996) Characterization and targeting of σ-receptor binding sites in human prostate tumor cells. J. Nucl. Med. 37, 205P (abstract).
15. (b) John, C. S., Gulden, M. E., Li, J., McAfee, J. G., Bowen, W. D., and Thakur, M. L. (1997) Synthesis, in-vitro binding and pharmacokinetics of radioiodinated (N-benzylpiperidin-4-yl)-2-iodobenzamide: σ-receptor marker for human prostate tumors. (Manuscript submitted for publication.)
16. (a) DiZio, J. P., Anderson, C. J., Davison, A., Ehrhardt, G. J., Carlson, K. E., Welch, M. J., and Katzenellenbogen, J. A. (1992) Technetium-and rhenium-labeled progestins: synthesis, receptor binding and in-vivo distribution of an 111-substituted progestin labeled with technetium-99 and rhenium-186. J. Nucl. Med. 33, 558-569.
17. 2-metal conjugate. Bioconjugate Chem. 5, 182-193.
18. Lever, S. Z., Baidoo, K. E., Mahmood, A., Matsumura, K., Scheffel, U., and Wagner, H. N. (1994) Novel technetium ligands with affinity for the muscarinic cholinergic receptors. Nucl. Med. Biol. 21, 157-164.
19. Del Rosario, R. B., Jung, Y.-W., Baidoo, K. E., Lever, S. Z., and Wieland, D. M. (1994) Synthesis and in vivo evaluation of a 99m/99Tc-DADT-benzovesamicol: a potential marker for cholinergic neurons. Nucl. Med. Biol. 21, 197-203.
20. de Costa, B. R., Radesca, L., Di Paolo, L., and Bowen, W. D. (1992) Synthesis, characterization and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the σ-receptors. J. Med. Chem. 35, 38-47.
21. de Costa, B. R., Radesca, L., Dominguez, C., Di Paolo, L., and Bowen, W. D. (1992) Synthesis and receptor binding properties of fluoro-and iodo-substituted high affinity σ-receptor ligands: Identification of potential PET and SPECT σ-receptor imaging agents. J. Med. Chem. 35, 2221-2230.
22. (a) John, C. S., Vilner, B. J., and Bowen, W. D. (1995) Synthesis, binding characteristics and in-vivo clearance of 4-[I-125]PEMP: a σ-receptor ligand for imaging tumors. J. Nucl. Med. 36, 6P (abstract).
23. 125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl)ethylamine: a high affinity ligand for imaging σ-receptor-positive tumors. Nucl. Med. Biol. 23, 761-766.
24. Joshua, A. V., Scott, J. R., Sondhi, S. M., Ball, R. G., and Lown, J. W. (1987) Transannular cyclizations of 1,2-dithia-5,8-diazacyclodeca-4,8-dienes during borohydride reduction. J. Org. Chem. 52, 2447-2451.
25. (a) DiZio, J. P., Fiaschi, R., Davison, A., Jones, A. G., and Katzenellenbogen, J. A. (1991) Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy. Bioconjugate Chem. 2, 353-366.
26. (b) Mahmood, A., Baidoo, K. E., and Lever, S. Z. (1990) Stereoisomers of neutral oxotechnetium(V) and oxorhenium(V) complexes. In Techneium in Chemistry and Nuclear Medicine (M. Nicolini, G. Bandoli, and U. Mazzi, Eds.) Vol. 3, pp 119-124, Cortina International, Verona.
27. Hellewell, S. B., Bruce, A., Feinstein, G., Orringer, J., Williams, W., and Bowen, W. D. (1994) Rat liver and kidney contain high densities of σ-1 and σ-2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268, 9-18.